STAAR Surgical EBITDA Margin 2010-2025 | STAA
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for STAAR Surgical (STAA) over the last 10 years. The current EBITDA margin for STAAR Surgical as of March 31, 2025 is .
| STAAR Surgical EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2025-03-31 |
$0.28B |
$-0.06B |
-21.79% |
| 2024-12-31 |
$0.31B |
$-0.01B |
-2.23% |
| 2024-09-30 |
$0.34B |
$0.03B |
8.80% |
| 2024-06-30 |
$0.33B |
$0.03B |
9.04% |
| 2024-03-31 |
$0.33B |
$0.03B |
8.00% |
| 2023-12-31 |
$0.32B |
$0.03B |
9.32% |
| 2023-09-30 |
$0.31B |
$0.02B |
6.45% |
| 2023-06-30 |
$0.31B |
$0.03B |
8.82% |
| 2023-03-31 |
$0.30B |
$0.04B |
12.20% |
| 2022-12-31 |
$0.28B |
$0.05B |
16.20% |
| 2022-09-30 |
$0.28B |
$0.05B |
19.00% |
| 2022-06-30 |
$0.26B |
$0.05B |
18.39% |
| 2022-03-31 |
$0.24B |
$0.04B |
17.36% |
| 2021-12-31 |
$0.23B |
$0.04B |
16.09% |
| 2021-09-30 |
$0.22B |
$0.03B |
15.67% |
| 2021-06-30 |
$0.21B |
$0.03B |
15.05% |
| 2021-03-31 |
$0.18B |
$0.02B |
10.61% |
| 2020-12-31 |
$0.16B |
$0.01B |
6.75% |
| 2020-09-30 |
$0.16B |
$0.01B |
5.77% |
| 2020-06-30 |
$0.15B |
$0.01B |
4.73% |
| 2020-03-31 |
$0.15B |
$0.01B |
7.84% |
| 2019-12-31 |
$0.15B |
$0.02B |
9.93% |
| 2019-09-30 |
$0.14B |
$0.01B |
9.79% |
| 2019-06-30 |
$0.14B |
$0.01B |
8.82% |
| 2019-03-31 |
$0.13B |
$0.01B |
8.46% |
| 2018-12-31 |
$0.12B |
$0.01B |
7.26% |
| 2018-09-30 |
$0.12B |
$0.01B |
5.93% |
| 2018-06-30 |
$0.11B |
$0.01B |
6.42% |
| 2018-03-31 |
$0.10B |
$0.00B |
3.09% |
| 2017-12-31 |
$0.09B |
$0.00B |
1.11% |
| 2017-09-30 |
$0.09B |
$0.00B |
3.45% |
| 2017-06-30 |
$0.08B |
0 |
0.00% |
| 2017-03-31 |
$0.08B |
$0.00B |
-1.20% |
| 2016-12-31 |
$0.08B |
$-0.01B |
-10.98% |
| 2016-09-30 |
$0.08B |
$-0.01B |
-12.35% |
| 2016-06-30 |
$0.08B |
$-0.01B |
-12.50% |
| 2016-03-31 |
$0.08B |
$-0.01B |
-12.82% |
| 2015-12-31 |
$0.08B |
$0.00B |
-2.56% |
| 2015-09-30 |
$0.07B |
$-0.01B |
-8.11% |
| 2015-06-30 |
$0.07B |
$-0.01B |
-8.22% |
| 2015-03-31 |
$0.07B |
$-0.01B |
-8.11% |
| 2014-12-31 |
$0.08B |
$-0.01B |
-8.00% |
| 2014-09-30 |
$0.08B |
$0.00B |
-5.19% |
| 2014-06-30 |
$0.08B |
$0.00B |
-2.63% |
| 2014-03-31 |
$0.07B |
0 |
0.00% |
| 2013-12-31 |
$0.07B |
$0.00B |
4.17% |
| 2013-09-30 |
$0.07B |
$0.00B |
4.35% |
| 2013-06-30 |
$0.07B |
$0.00B |
2.94% |
| 2013-03-31 |
$0.07B |
$0.00B |
1.52% |
| 2012-12-31 |
$0.06B |
0 |
0.00% |
| 2012-09-30 |
$0.06B |
$0.00B |
3.13% |
| 2012-06-30 |
$0.06B |
$0.00B |
4.76% |
| 2012-03-31 |
$0.06B |
$0.01B |
7.94% |
| 2011-12-31 |
$0.06B |
$0.01B |
8.06% |
| 2011-09-30 |
$0.06B |
$0.00B |
6.67% |
| 2011-06-30 |
$0.06B |
$0.00B |
3.45% |
| 2011-03-31 |
$0.06B |
0 |
0.00% |
| 2010-12-31 |
$0.06B |
0 |
0.00% |
| 2010-09-30 |
$0.05B |
$0.00B |
1.85% |
| 2010-06-30 |
$0.05B |
$0.00B |
3.77% |
| 2010-03-31 |
$0.05B |
$0.00B |
3.85% |
| 2009-12-31 |
$0.05B |
0 |
0.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.937B |
$0.314B |
|
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
|
